ories Market, Brazil, Company Revenue ($m), 2010 61Table 38: Micro-Electromechanical Systems Market, China, Revenue ($m), 2003-2010 63Table 39: Micro-Electromechanical Systems Market, China, Revenue ($m), 2010-2017 64Table 40: Micro-Electromechanical Systems Market, India, Revenue ($m), 2003-2010 65Table 41: Micro-Electromechanical Systems Market, India, Revenue ($m), 2010-2017 66Table 42: Micro-Electromechanical Systems Market, Brazil, Revenue ($m), 2003-2010 67Table 43: Micro-Electromechanical Systems Market, Brazil, Revenue ($m), 2010-2017 68Table 44: Neonatal Monitors Market, China, Revenue ($m), 2003-2010 71Table 45: Neonatal Monitors Market, China, Revenue ($m), 2010-2017 72Table 46: Neonatal Monitors Market, India, Revenue ($m), 2003-2010 73Table 47: Neonatal Monitors Market, India, Revenue ($m), 2010-2017 74Table 48: Neonatal Monitors Market, Brazil, Revenue ($m), 2003-2010 75Table 49: Neonatal Monitors Market, Brazil, Revenue ($m), 2010-2017 76Table 50: Neonatal Monitors Market, China, Company Revenue ($m), 2010 77Table 51: Neonatal Monitors Market, India, Company Revenue ($m), 2010 78Table 52: Neonatal Monitors Market, Brazil, Company Revenue ($m), 2010 79Table 53: Remote Patient Monitoring Equipment Market, India, Revenue ($m), 2003-2010 82Table 54: Remote Patient Monitoring Equipment Market, India, Revenue ($m), 2010-2017 83Table 55: Remote Patient Monitoring Equipment Market, Brazil, Revenue ($m), 2003-2010 84Table 56: Remote Patient Monitoring Equipment Market, Brazil, Revenue ($m), 2010-2017 85Table 57: Remote Patient Monitoring Equipment Market, India, Company Revenue ($m), 2010 86Table 58: Patient Monitoring Equipment Market, Brazil, Company Revenue ($m), 2010 87Table 59: Fetal Monitors Market, China, Revenue ($m), 2003-2010 91Table 60: Fetal Monitors Market, China, Revenue ($m), 2010-2017 92Table 61: Fetal Monitors Market, India, Revenue ($m), 2003-2010 93Table 62: Fetal Monitors Market, India, Revenue ($m), 2010-2017 94Table 63: Antepartum Monitor
'/>"/>SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average2.
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-20123.
Watching, Reading and Listening: A New Way to Interact with Patient Information4.
Phreesia identifies over 26% of patients who require additional autism evaluation5.
Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study6.
Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan7.
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma8.
New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease9.
Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance10.
Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date11.
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way